Alcon acquires Aerie Pharmaceuticals to expand eye care business
Alcon, an American Swiss medical company specializing in eye care products, has closed the previously announced $930 million acquisition of Aerie Pharmaceuticals, a NASDAQ-based pharmaceutical company. The acquisition is expected to strengthen Alcon’s ophthalmic pharmaceutical business through the addition of Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, and Rhopressa (netarsudil ophthalmic solution) 0.02%. Besides, Alcon […]